Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.47
-0.27 (-3.49%)
May 18, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Aura Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $18.8. The average 1-year stock price forecast is 151.67% higher than the current stock price, while the lowest is $15 (+100.80%) and the highest is $24 (+221.29%).
Price Target: $18.8 (+151.67%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Aura Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 3 | 3 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $24 | Strong Buy | Maintains | $22 → $24 | +221.29% | Apr 29, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +194.51% | Mar 30, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $13 | Buy | Initiates | $13 | +74.03% | Nov 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +194.51% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +194.51% | May 28, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
15.75M
EPS This Year
-1.63
from -1.76
EPS Next Year
-1.64
from -1.63
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | n/a | 20.7M | |||||
| Avg | n/a | 15.7M | |||||
| Low | n/a | 11.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | - | - | |||||
| Avg | - | - | |||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.59 | -1.63 | |
| Avg | -1.63 | -1.64 | |
| Low | -1.72 | -1.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.